A
Andrew J Ahmann
Researcher at Ford Motor Company
Publications - 2
Citations - 423
Andrew J Ahmann is an academic researcher from Ford Motor Company. The author has contributed to research in topics: Randomized controlled trial & Type 2 diabetes. The author has an hindex of 2, co-authored 2 publications receiving 255 citations. Previous affiliations of Andrew J Ahmann include Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial
Roy W. Beck,Tonya D Riddlesworth,Katrina J. Ruedy,Andrew J Ahmann,Stacie Haller,Davida F. Kruger,Janet B. McGill,William H. Polonsky,David C. Price,Stephen Aronoff,Ronnie Aronson,Elena Toschi,Craig Kollman,Richard M Bergenstal +13 more
TL;DR: A high percentage of adults who received multiple daily insulin injections for type 2 diabetes used CGM on a daily or near-daily basis for 24 weeks and had improved glycemic control, and these results support an additional management method that may benefit patients.
Journal ArticleDOI
Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial
Roy W. Beck,Tonya D Riddlesworth,Katrina J. Ruedy,Craig Kollman,Andrew J Ahmann,Richard M Bergenstal,Anuj Bhargava,Bruce W. Bode,Stacie Haller,Davida F. Kruger,Janet B. McGill,William H. Polonsky,David Price,Elena Toschi,Howard Wolpert,Astrid Atakov-Castillo,Edvina Markovic,Stephen Aronoff,Satanya Brooks,Gloria Martinez,Angela Mendez,Theresa Dunnam,Kathy Fitzgerald,Diana Wright,Teck Khoo,Pierre Theuma,Tara Herrold,Debra Thomsen,Richard M. Bergenstal,Kathleen McCann,Arlene Monk,Char Ashanti,David Liljenquist,Heather Judge,Jean Halford,Davida Kruger,Shiri Levy,Arti Bhan,Terra Cushman,Lameka Dawson,Heather Remtema,Fawn Wolf,James Neifing,Jennifer Murdoch,Susan Staat,Tamara Mayfield,Andrew J. Ahmann,Bethany Klopfenstein,Farahnaz Joarder,Kathy Hanavan,Jessica R. Castle,Diana Aby-Daniel,Victoria Morimoto,Donald DeFrang,Bethany Wollam,Janet B. McGill,Olivia Jordan,Carol Recklein,Mark Kipnes,Terri Ryan,Bruce W. Bode,Jennifer Boyd,Nitin Rastogi,Katherine Lindmark,William Biggs,Lorena Sandoval,Robin Eifert,Becky Cota,Quang Nguyen,Alejandra Martinez,Cathy Duran,Scott Segel,David Sutton,Miguel Roura,Rebecca Rosenwasser,Jennifer McElveen,Emily Knisely,Anne Johnson,A. Ola Odugbesan,Karla Wardell,Carolyn Paulus,Jack Wahlen,Jon Winkfield,Hilary Wahlen,Emily Hepworth,David Winkfield,Sue Owens,Steven Leichter,Emily Evans,Sarah Konigsberg,Jennifer Rahman,Linda Gaudiani,Natalie Woods,Jesse Cardozo,Kate Wheeler,Jennifer Kane,Terri Eubanks,Katrina Ruedy,Tonya Riddlesworth,Thomas Mouse,Eileen Casal,Claudia Graham +101 more
TL;DR: The findings show that glycaemic control measured by time in the glucose range of 70-180 mg/dL (3·9-10·0 mmol/L) is improved by initiation of CSII in adults with type 1 diabetes.